These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 24867957)

  • 1. N-glycosylation is required for matriptase-2 autoactivation and ectodomain shedding.
    Jiang J; Yang J; Feng P; Zuo B; Dong N; Wu Q; He Y
    J Biol Chem; 2014 Jul; 289(28):19500-7. PubMed ID: 24867957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolytic processing of the serine protease matriptase-2: identification of the cleavage sites required for its autocatalytic release from the cell surface.
    Stirnberg M; Maurer E; Horstmeyer A; Kolp S; Frank S; Bald T; Arenz K; Janzer A; Prager K; Wunderlich P; Walter J; Gütschow M
    Biochem J; 2010 Aug; 430(1):87-95. PubMed ID: 20518742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct roles of N-glycosylation at different sites of corin in cell membrane targeting and ectodomain shedding.
    Wang H; Zhou T; Peng J; Xu P; Dong N; Chen S; Wu Q
    J Biol Chem; 2015 Jan; 290(3):1654-63. PubMed ID: 25451932
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Matriptase shedding is closely coupled with matriptase zymogen activation and requires de novo proteolytic cleavage likely involving its own activity.
    Tseng CC; Jia B; Barndt R; Gu Y; Chen CY; Tseng IC; Su SF; Wang JK; Johnson MD; Lin CY
    PLoS One; 2017; 12(8):e0183507. PubMed ID: 28829816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mild acidity likely accelerates the physiological matriptase autoactivation process: a comparative study between spontaneous and acid-induced matriptase zymogen activation.
    Jia B; Thompson HA; Barndt RB; Chiu YL; Lee MJ; Lee SC; Wang JK; Tang HJ; Lin CY; Johnson MD
    Hum Cell; 2020 Oct; 33(4):1068-1080. PubMed ID: 32779152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostasin is required for matriptase activation in intestinal epithelial cells to regulate closure of the paracellular pathway.
    Buzza MS; Martin EW; Driesbaugh KH; Désilets A; Leduc R; Antalis TM
    J Biol Chem; 2013 Apr; 288(15):10328-37. PubMed ID: 23443662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of asparagine-linked glycosylation site on the catalytic domain of matriptase in its zymogen activation.
    Miyake Y; Tsuzuki S; Mochida S; Fushiki T; Inouye K
    Biochim Biophys Acta; 2010 Jan; 1804(1):156-65. PubMed ID: 19800422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Production of soluble matriptase by human cancer cell lines and cell surface activation of its zymogen by trypsin.
    Jin X; Hirosaki T; Lin CY; Dickson RB; Higashi S; Kitamura H; Miyazaki K
    J Cell Biochem; 2005 Jun; 95(3):632-47. PubMed ID: 15832373
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights into the regulation of the matriptase-prostasin proteolytic system.
    Holt-Danborg L; Skovbjerg S; Goderum KW; Nonboe AW; Stankevic E; Frost ÁK; Vitved L; Jensen JK; Vogel LK
    Biochem J; 2020 Nov; 477(22):4349-4365. PubMed ID: 33094801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactive matriptase-2 mutants found in IRIDA patients still repress hepcidin in a transfection assay despite having lost their serine protease activity.
    Guillem F; Kannengiesser C; Oudin C; Lenoir A; Matak P; Donadieu J; Isidor B; Méchinaud F; Aguilar-Martinez P; Beaumont C; Vaulont S; Grandchamp B; Nicolas G
    Hum Mutat; 2012 Sep; 33(9):1388-96. PubMed ID: 22581667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blocking the proteolytic activity of zymogen matriptase with antibody-based inhibitors.
    Tamberg T; Hong Z; De Schepper D; Skovbjerg S; Dupont DM; Vitved L; Schar CR; Skjoedt K; Vogel LK; Jensen JK
    J Biol Chem; 2019 Jan; 294(1):314-326. PubMed ID: 30409910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.
    Silvestri L; Pagani A; Nai A; De Domenico I; Kaplan J; Camaschella C
    Cell Metab; 2008 Dec; 8(6):502-11. PubMed ID: 18976966
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The protease inhibitor HAI-2, but not HAI-1, regulates matriptase activation and shedding through prostasin.
    Friis S; Sales KU; Schafer JM; Vogel LK; Kataoka H; Bugge TH
    J Biol Chem; 2014 Aug; 289(32):22319-32. PubMed ID: 24962579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Roles of CUB and LDL receptor class A domain repeats of a transmembrane serine protease matriptase in its zymogen activation.
    Inouye K; Tomoishi M; Yasumoto M; Miyake Y; Kojima K; Tsuzuki S; Fushiki T
    J Biochem; 2013 Jan; 153(1):51-61. PubMed ID: 23038671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A matriptase-prostasin reciprocal zymogen activation complex with unique features: prostasin as a non-enzymatic co-factor for matriptase activation.
    Friis S; Uzzun Sales K; Godiksen S; Peters DE; Lin CY; Vogel LK; Bugge TH
    J Biol Chem; 2013 Jun; 288(26):19028-39. PubMed ID: 23673661
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of matriptase zymogen.
    Kojima K; Inouye K
    J Biochem; 2011 Aug; 150(2):123-5. PubMed ID: 21737400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The catalytic, stem, and transmembrane portions of matriptase-2 are required for suppressing the expression of the iron-regulatory hormone hepcidin.
    Mao P; Wortham AM; Enns CA; Zhang AS
    J Biol Chem; 2019 Feb; 294(6):2060-2073. PubMed ID: 30559294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human cancer cells retain modest levels of enzymatically active matriptase only in extracellular milieu following induction of zymogen activation.
    Chu LL; Xu Y; Yang JR; Hu YA; Chang HH; Lai HY; Tseng CC; Wang HY; Johnson MD; Wang JK; Lin CY
    PLoS One; 2014; 9(3):e92244. PubMed ID: 24663123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The activation of matriptase requires its noncatalytic domains, serine protease domain, and its cognate inhibitor.
    Oberst MD; Williams CA; Dickson RB; Johnson MD; Lin CY
    J Biol Chem; 2003 Jul; 278(29):26773-9. PubMed ID: 12738778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoactivation and calpain-1-mediated shedding of hepsin in human hepatoma cells.
    Wang L; Zhang C; Sun S; Chen Y; Hu Y; Wang H; Liu M; Dong N; Wu Q
    Biochem J; 2019 Aug; 476(16):2355-2369. PubMed ID: 31395734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.